Entrada Therapeutics, Inc.
Key Metrics
Market Snapshot
About
Entrada Therapeutics is a clinical-stage biotechnology company developing intracellular therapeutics using its Endosomal Escape Vehicle (EEV) platform. The company focuses on treating diseases by enabling the delivery of therapeutic molecules into cells, targeting oncology and neuromuscular disorders. Entrada is advancing multiple programs through clinical trials to address significant unmet medical needs.